Can't connect right now! retry
health
Monday Jul 19 2021
By
Web Desk

Pakistan honoured with international award for excellence in public health response

By
Web Desk
Pakistan has been given the Directors Award for Excellence in Epidemiology And Public Health Response.
Pakistan has been given the Directors Award for Excellence in Epidemiology And Public Health Response.

  • NIH has been conferred the award for its contribution in the field of epidemiology and public health emergency response.
  • The award is considered as the highest achievement award toward successful responses to public health emergencies.
  • The award is also to recognise excellence in epidemiologic research.


ISLAMABAD: In recognition of its contribution to the field of epidemiology and public health emergency response, Pakistan's National Institute of Health (NIH) Islamabad has been conferred the Director's Award during the Field Epidemiology Training Programme (FETP) and Epidemic Intelligence Service (EIS) International Conference 2021 held at the Centres for Disease Control and Prevention (CDC) in the United States.

The Director's Award for Excellence is considered the highest achievement accolade for countries that have made significant contributions toward successful responses to public health emergencies.

The award is also to recognise excellence in epidemiologic research and contributions that address public health issues by applying epidemiologic principles and methods.

Earlier, the National Institute of Health (NIH) had been working on a plan to develop a single-dose coronavirus vaccine for Pakistan.

"Our team is ready to undertake this task, while a Chinese team is already here to oversee the exercise," NIH Executive Director Major General Aamer Ikram told the National Assembly standing committee on national health services.

He had said the NIH had carried out a clinical trial of the Chinese COVID-19 vaccine CanSinoBio, placing the country among the first few to do so.

China had been formally asked to transfer the vaccine technology and raw material for the vaccine will reach the country shortly, the NIH official had said.